NEW YORK (GenomeWeb News) – Cellular Dynamics said after the close of the market on Monday that its revenues for the fourth quarter increased 45 percent year over year.

The Madison, Wis.-based developer of fully functional human cells for research applications reported total revenues of $4.2 million for the three months ended Dec. 31, 2013, up from $2.9 million in the year-ago fourth quarter. Product sales rose 9 percent to $2.5 million from $2.3 million, while revenues from collaborations, partnerships, and other sources more than doubled to $1.7 million from $657,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.